VTVT News and Press, vTv Therapeutics Inc. From 09/24/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s the last day of the trading week and that we’re starting it off with a dive into Friday’s biggest pre-market stock movers! Source: f11photo/Shutterstock.com Earnings r...

HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous multiple ascending dose study and support advancement of HPP737 into Phase 2 in moderate to severe psoriasis. Successful pr...

vTv Therapeutics (NASDAQ:VTVT): Q2 GAAP EPS of -$0.01. Revenue of $9K vs. $987K in Q1 2021. Press Release For further details see: vTv Therapeutics reports Q2 results

HIGH POINT, N.C., Aug. 04, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter ended June 30, 2021, and provided an update on the progress of its clinical programs. “We held our first, highly-productive meetin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech penny stocks is somewhat like pursuing a career in TV acting: It’s not easy to succeed, but if you do so, your rewards can be truly fantastic. Further, just as many unsuccessful actors make lit...

HIGH POINT, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that it will be presenting data from th...

10 Hot Biotech Penny Stocks For Your Watchlist Next Month Biotech penny stocks are heating up right now. While this began a few months after the onset of Covid, since then, penny stocks in the biotech sector have continued to make headway. One thing to keep in mind is that biotech...

vTv Therapeutics (VTVT) +28% on licensing agreement with Cantex.Adial Pharmaceuticals (ADIL) +22%.Bio-Path Holdings (BPTH) +22% as USPTO grants a new patent.Beyond Air (XAIR) +12%.Sanderson Farms (SAFM) +12% as it explores a potential sale.Idera Pharmaceuticals (IDRA) +11%.Insp...

vTv Therapeutics (VTVT) have entered into a licensing agreement under which Cantex has obtained exclusive worldwide rights to develop and commercialize azeliragon.Azeliragon, also known as TTP488, is an orally active, small molecule, antagonist of the receptor for advanced glycation endp...

HIGH POINT, N.C. and WESTON, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (“vTv”, Nasdaq:VTVT) and Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that they have entered into a licensing agreement under which Cantex has obtained exclu...